Roche's Accutane Warning Passes Muster In MDL
Hoffmann-La Roche Inc. adequately warned an Accutane user about the risk of developing inflammatory bowel disease while on the acne drug, a Florida federal judge overseeing multidistrict litigation ruled Tuesday, a...To view the full article, register now.
Already a subscriber? Click here to view full article